Twist Bioscience Corp reports results for the quarter ended December 31 - Earnings Summary

Twist Bioscience

03/02/2025 14:31

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of 53 cents​​ per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of -75 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 63 cents per
share. Wall Street expected results to range from -76 cents
to -51 cents per share.
    * Revenue rose 24.1% to $88.71 million from a year ago;
analysts
expected $86.97 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of 53 cents​.
    * The company reported a quarterly loss of $31.59 million.
    * Twist Bioscience Corp shares had risen by 12.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Twist Bioscience
Corp is $54.00 
This summary was machine generated from LSEG data February 3 at
02:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.63          -0.53          Beat
 Sep. 30 2024      -0.71          -0.59          Beat
 Jun. 30 2024      -0.77          -1.47          Missed
 Mar. 31 2024      -0.82          -0.79          Beat